Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer : a Randomized, Open-label, Parallel-controlled, Multi-center Phase III Study (NEOTORCH-BREAST04)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Hangzhou, China
Not, yet, recruiting - the First Affiliated Hospital of Zhejiang University
Hangzhou, China
Recruiting - Zhejiang Cancer Hospital
Hangzhou, China
Recruiting - Harbin Medical University Cancer Hospital
Harbin, China
Not, yet, recruiting - the First Affiliated Hospital of Anhui Medical University
Hefei, China
Not, yet, recruiting - Jinhua Municipal Central Hospital
Jinhua, China
Not, yet, recruiting - Nanchang People'S Hospital
Nanchang, China
Not, yet, recruiting - Nantong First People'S Hospital
Nantong, China
Not, yet, recruiting - Zhongshan Hospitall, Fudan University
Shanghai, China
Not, yet, recruiting - Shaanxi Provincial Cancer Hospital
Xi'an, China
Not, yet, recruiting - the Second Affiliated Hospital of Xi'An Jiaotong University
Xi'an, China
Not, yet, recruiting - the First Affiliated Hospital of Zhengzhou University
Zhengzhou, China
Not, yet, recruiting - Xinjiang Medical University Affiliated Cancer Hospital
Ürümqi, China
Not, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Mar 2025
- Primary completion
- 23 Mar 2027
- Completion
- 23 Mar 2030
- Last update posted
- 18 May 2025
- Registered enrollment
- 194
- Registry id
- NCT06977893
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.